$5.62
0.04 (+0.72%)
Maxygen, Inc. (MAXY)
CAPS Rating:
A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

RSS Headlines
Fool UK